Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Understanding the Role of the Human Metagenome in Obesity, Metabolic Diseases, Chronic Inflammation, Sarcopenia and Sarcopenic Obesity - a Pilot Study

NCT06363253 is registered in ClinicalTrials.gov with Sengkang General Hospital as lead sponsor.

NCT NCT06363253
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06363253 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Understanding the Role of the Human Metagenome in Obesity, Metabolic Diseases, Chronic Inflammation, Sarcopenia and Sarcopenic Obesity - a Pilot Study
Lead sponsor
Sengkang General Hospital
Phase
Observational
Overall status
Recruiting
Start date
August 14, 2023
Completion date
December 31, 2027
Enrollment
600 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic inflammation, metabolic syndrome, obesity, sarcopenia, sarcopenic obesity